Céline Gongora

12PUBLICATIONS
56CO-AUTHORS
Predictive and prognostic markersMolecular targetsCheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 03, 2026
P38MAPK targeting in pancreatic ductal adenocarcinoma: Promising interventional approach for breaking drug resistance and tumor control.

|Oct 21, 2025
TopBP1 biomolecular condensates as a new therapeutic target in advanced-stage colorectal cancer.

Laura Morano, Nadia Vezzio-Vié, Adam Aissanou

|Oct 01, 2025
Targeting SUV4-20H Epigenetic Enzymes Enhances Topoisomerase II Poisoning in Prostate Cancer.

Fatima Alhourani, Marine Tauziet, Margaux Ayeul

|Jun 09, 2025
Inhibiting microtubule polymerization with EAPB02303, a prodrug activated by catechol-O-methyl transferase, enhances paclitaxel effect in pancreatic cancer models.

Kévin Bigot, Cindy Patinote, Véronique Garambois

|Mar 26, 2025
Oxaliplatin, ATR inhibitor and anti-PD-1 antibody combination therapy controls colon carcinoma growth, induces local and systemic changes in the immune compartment, and protects against tumor rechallenge in mice.

Alexandra Fauvre, Chiara Ursino, Veronique Garambois

|Sep 13, 2024
STING-ATF3/type I interferon crosstalk: A potential target to improve anti-tumour immunity in chemotherapy-treated urothelial carcinoma.

Alexandra Fauvre, Margot Machu, Audrey Merienne

Pageof 2

Frequent Collaborators

5 joint publications

Philippe Pourquier

2 joint publications

Patrick Balaguer

2 joint publications

Diego Tosi

1 joint publications

Nicolas Creusot